In Reply: Association of Central Nervous System–Affecting Medications With Occurrence and Short-Term Mortality of Traumatic Brain Injury-Reference-Cited by-同舟云学术

In Reply: Association of Central Nervous System–Affecting Medications With Occurrence and Short-Term Mortality of Traumatic Brain Injury

Published:2024-06-11 Issue: Volume: Page:
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Posti Jussi P.¹^ORCID,Cajanus Kristiina²,Ruuskanen Jori O.³,Luoto Teemu M.⁴,Rautava Päivi⁵,Tornio Aleksi²,Kytö Ville⁵⁶

Affiliation:

1. Neurocenter, Department of Neurosurgery and Turku Brain Injury Center, Turku University Hospital and University of Turku, Turku, Finland

2. Department of Clinical Pharmacology, Turku University Hospital and University of Turku, Turku, Finland

3. Neurocenter, Department of Neurology, Turku University Hospital and University of Turku, Turku, Finland

4. Department of Neurosurgery, Tampere University Hospital and Tampere University, Tampere, Finland

5. Clinical Research Center, Turku University Hospital and University of Turku, Turku, Finland

6. Heart Centre, Turku University Hospital and University of Turku, Turku, Finland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Association of central nervous system–affecting medications with occurrence and short-term mortality of traumatic brain injury;Cajanus;Neurosurgery.,2024

2. Letter: Association of central nervous system-affecting medications with occurrence and short-term mortality of traumatic brain injury;Angelova;Neurosurgery.,2024

3. Risk for intracranial hemorrhage in individuals after mild traumatic brain injury who are taking serotonergic antidepressants;Isokuortti;Front Neurol.,2022

4. Serotonergic antidepressants and risk for traumatic intracranial bleeding;Isokuortti;Front Neurol.,2021

5. Use of serotonergic drugs and the risk of bleeding;Verdel;Clin Pharmacol Ther.,2011